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by damage to neurons and mechanosensitive hair cells, which
do not regenerate to any clinically relevant extent in humans.
Several protocols have been devised to direct pluripotent stem cells
(PSCs) into inner ear hair cells and neurons, which display many
properties of their native counterparts. The efficiency, reproduc-
ibility, and scalability of these protocols are enhanced by incorpo-
rating knowledge of inner ear development. Modeling human dis-
eases in vitro through genetic manipulation of PSCs is already
feasible, thereby permitting the elucidation of mechanistic under-
standings of a wide array of disease etiologies. Early studies on
transplantation of PSC-derived otic progenitors have been success-
ful in certain animal models, yet restoration of function and long-
term cell survival remain unrealized. Through further research,
PSC-based approaches will continue to revolutionize our under-
standing of inner ear biology and contribute to the development
of therapeutic treatments for inner ear disorders.Introduction
It is estimated that 15% of the world’s population has some
degree of hearing loss (WHO, https://www.who.int/pbd/
deafness/estimates/en/). In the US, approximately 35% of
individuals over the age of 40 years have balance dysfunc-
tion and the prevalence increases with age (Agrawal et al.,
2013). Hearing loss and vestibular disorders can stem
from various causes, including genetic defects, environ-
mental exposures, aging, and ototoxicmedications. The in-
ner ear is composed of the cochlea and vestibular organs
(utricle, saccule, and three semicircular canals) and each
harbors mechanosensory hair cells that convert mechani-
cal stimuli (i.e., sound or head motion) into electrical sig-
nals in afferent sensory neurons through synaptic trans-
mission. These electrical signals in the vestibulocochlear
nerve are then transmitted to the brainstem and subse-
quently the auditory cortex in the brain. Injury to the sen-
sory hair cells, the vestibulocochlear nerve, or the synaptic
connections between them can result in hearing loss and/
or vertigo. The lack of meaningful regenerative capacity of
the inner ear sensory cells of mammals means loss of func-
tion is permanent.
Extensive studies using animal models (e.g., frog, zebra-
fish, birds, and mammals) have advanced our knowledge
of the human inner ear function and disease. Access to hu-
man inner ear tissues is severely limited since tissue sam-
pling is technically challenging and leads to irreparable996 Stem Cell Reports j Vol. 14 j 996–1008 j June 9, 2020 j ª 2020 The Auth
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as computed tomography or MRI, currently do not provide
sufficient resolution to determine most pathologies of the
inner ear (Kayyali et al., 2018). Pathologies ofmany human
inner ear disorders can currently only be acquired by post-
mortem examinations.
In addition, access to inner ear tissues in mammalian an-
imal models is also limited, which has slowed progress in
the field. The sensory structures of the mammalian inner
ear are surrounded by rigid bone and opening this rigid
bone can lead to damage of the delicate cellular structures.
In addition, cochlear explant cultures from mice are only
technically feasible before postnatal day 7 (P7) (Ogier
et al., 2019) and cannot be maintained for longer than
2 weeks (Parker et al., 2010; Sobkowicz et al., 1993).
Although other animal models (e.g., zebrafish) have more
accessible hair cells, there are significant innate differences
between non-mammalian vertebrate and mammalian
models, such as the capacity for spontaneous hair cell
regeneration (Kniss et al., 2016; Warchol and Corwin,
1996). To overcome these limitations associated with the
current animal models, alternative model systems that
are sustainable, easily accessible, and easily manipulated
in the laboratory are needed for furthering our understand-
ing of the inner ear biology and pathology.
Over the past few decades, stem cell biology has acceler-
ated research into the pathologicmechanisms of Parkinson
disease and cardiac tissue regeneration (Beltrami et al.,
2003; Johnson and Hockemeyer, 2015). Currently, the
mature mammalian cochlea completely lacks the capacity
to spontaneously proliferate or regenerate hair cells and
there is very limited regeneration potential in the vestib-
ular system (Forge et al., 1993;Warchol et al., 1993). Activa-
tion of quiescent progenitor cells residing in the sensory
epithelium of the inner ear or replacing missing hair cells
with new hair cells derived from pluripotent stem cells
(PSCs) could be a potential cure. Despite the identification
of multipotent cell populations in the human fetal cochlea
and in the adult human spiral ganglion, no proliferative
cell populations with the capacity to give rise to hair cells
have been reported in adult humans (Senn et al., 2020).
Scientists have successfully derived inner ear progenitors
and inner ear sensory cells from both multipotent and
PSCs.Multipotent stem cells (i.e., somatic stem cells) exhibitor(s).
ecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Applications of PSCs in the Inner Ear
Mouse- and human-derived ESCs and iPSCs can be induced to form otic epithelial progenitors (OEPs), hair cells, sensory neurons, and 3D
organoids, which have scientific and therapeutic applications. ONP, otic neural progenitor.
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cell types within an organ in which those stem cells reside.
In contrast, PSCs (embryonic stem cells [ESCs] and induced
pluripotent stem cells [iPSCs]) have infinite self-renewal ca-
pacity and the ability to differentiate into any cell type of the
three major germ layers. Somatic stem cells, such as mesen-
chymal stem cells and neural stem cells, have been used to
generate inner ear progenitors and restore damaged spiral
ganglia (Boddy et al., 2012; Mittal et al., 2020; Xu et al.,
2016). However, there are a limited number of sources for
these somatic stem cells and they exhibit a restricted capac-
ity for differentiation (Clevers, 2015). On the contrary, PSCs
are relatively easy to bemaintained in culture and can differ-
entiate into essentially any cell types (Rossant and Papaioan-
nou, 1984; Yilmaz and Benvenisty, 2019). Furthermore,
genetically reprogramed iPSCs (Takahashi et al., 2007; Taka-
hashi and Yamanaka, 2006) offer unique opportunities for
personalized medicine, because the iPSCs can be derived
from patients’ own cells and they are resistant to immuno-
compatibility issues (Johnson and Hockemeyer, 2015; Yil-
maz and Benvenisty, 2019).
Here, we review the progress of in vitro derivation of PSC-
derived inner ear hair cells, neurons, and organoids (Fig-ure 1). We highlight the use of these PSC-derived tissues
to understand the mechanisms of inner ear diseases and
to restore inner ear function in early therapeutic trials
(Figure 1).
Derivation of Inner Ear Tissues from PSCs
Understanding the complex sequence of transcriptional
changes and signaling pathways that underlie in vivo inner
ear development is critical to the successful differentiation
of PSCs into inner ear tissues, such as hair cells, supporting
cells, and neurons in vitro (Czajkowski et al., 2019; Roccio
and Edge, 2019).
Hair Cells and Sensory Epithelia
Numerous induction protocols have been developed to
differentiate PSCs into hair cell-like cells (Figures 2 and
3). Many of these protocols start with the generation of
floating embryoid bodies (i.e., aggregated cell masses) fol-
lowed by stepwise treatments of a combination of small
molecules and/or recombinant proteins that become ad-
hesive 2D cultures after approximately 5 days (Abboud
et al., 2017; Li et al., 2003; Oshima et al., 2010; Ouji
et al., 2012; Ronaghi et al., 2014). Other protocols are car-
ried out entirely in 2D culture, which can provide aStem Cell Reports j Vol. 14 j 996–1008 j June 9, 2020 997
Figure 2. Hair Cell-like Cells Derived from PSCs
Summary of induction strategies and characterization of both mouse and human PSC-derived hair cell-like cells. Petri dishes reflect ad-
hesive 2D cnuultures, cell aggregates represent 3D floating cultures, and capsules represent rotary cultures. Characterization method
highlighted in orange, key molecular markers (percentage of cells expressing) and mechanosensitivity are indicated. EB, embryonic body;
d, day in culture; KOSR, knockout serum replacement; RA, retinoic acid.
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et al., 2016; Lahlou et al., 2018a; Ohnishi et al., 2015).
In contrast, 3D organoid systems contain multiple cell
types and more precisely recapitulate in vivo composition
of an organ. In 2013, the first 3D inner ear organoid sys-
tem was developed using mESCs (Figure 3) (Koehler et al.,
2013).
The initial steps of inner ear development require the for-
mation of the ectodermal germ layer followed by formation
of the pre-placodal ectoderm (PPE). Protocols first inhibit
transforming growth factor b and WNT signaling and acti-
vate BMP to promote non-neural ectodermal development,998 Stem Cell Reports j Vol. 14 j 996–1008 j June 9, 2020while reducing mesoderm development (Figures 2 and 3)
(Abboud et al., 2017; Koehler et al., 2013, 2017; Lahlou
et al., 2018a; Oshima et al., 2010; Ronaghi et al., 2014). In-
sulin-like growth factor 1 promotes the fate of the anterior
ectoderm, where the PPE emerges (Figure 2) (Li et al., 2003;
Ronaghi et al., 2014). The PPE gives rise to most of the cra-
nial placodes, including the otic placode. Fibroblast growth
factor (FGF) signaling (FGF3/10 in mouse) is the main
inducer of the posterior domain of the PPE that gives rise
to otic placode. WNT activation along with FGF signaling
facilitates otic placode induction (Singh and Groves,
2016) (Figures 2 and 3).
Figure 3. Organoids Derived from PSCs
Summary of induction strategies and characterization of both mouse and human PSC-derived organoids. Cell aggregates represent 3D
floating cultures. Characterization method highlighted in orange, key molecular markers (percentage of cells expressing) and mecha-
nosensitivity are indicated. ABR, auditory brainstem response; d, culture day; EB, embryonic body; RA, retinoic acid.
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matrices, such as Matrigel, improve the efficiency of differ-
entiation, as well as the resulting cellular assemblage (Jeong
et al., 2018; Koehler et al., 2013, 2017; Mattei et al., 2019).
For example, addition of Matrigel in the 3D inner ear orga-
noid systems established by Koehler et al. (2013, 2017) facil-
itated formation of fluid-filled vesicles containing hair cells
and supporting cell-like cells (Figure 3). However, vestibular
tissue-like organoids derived from hPSCs using the rotary
cell culture system form hair cell-like cells on the surface
of the organoids (Figure 2) (Mattei et al., 2019). At present,
detailed mechanisms as to how extracellular matrices influ-
ence cell differentiation and survival are still unclear.Specific PSC-derived cells along the developmental otic
lineage are verified via expression of molecular markers,
morphological examinations, and/or electrophysiological
measurements (Chen et al., 2012; Koehler et al., 2017; Li
et al., 2003; Oshima et al., 2010). SIX1 and E-cadherin
expression are used to identify cells within the PPE (Oh-
nishi et al., 2015; Tchieu et al., 2017). PAX8 and PAX2
mark the posterior PPE (i.e., otic-epibranchial placodal
domain, Figures 2 and 3) and are used to identify the otic
progenitor cells within PSC-derived inner ear tissues
(Chen et al., 2012; Jeong et al., 2018; Lahlou et al.,
2018a). Induction of hair cells from the posterior PPE re-
quires either endogenous WNT or supplementation withStem Cell Reports j Vol. 14 j 996–1008 j June 9, 2020 999
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expression of BRN3C (also known as POU4F3), MYO7A,
and ATOH1 (Abboud et al., 2017; Koehler et al., 2013,
2017; Oshima et al., 2010). Because native hair cells exhibit
unique mechanosensitivity, patch-clamp recordings have
been used to assess functional properties of PSC-derived
hair cells. While the net potassium voltage gradient is
most commonly recorded (Chen et al., 2012; Ding et al.,
2016; Koehler et al., 2017), only a few studies have success-
fully recorded mechanotransduction currents from PSC-
derived hair cells by deflecting hair bundles (Liu et al.,
2016; Oshima et al., 2010). To date, PSC-derived hair cell-
like cells display molecular markers and electrophysiolog-
ical properties of vestibular hair cells and not cochlear
hair cells. Discovery of alternative small molecules or cul-
ture conditions to generate cochlear hair cells from PSCs
is still needed.
Induction protocols require optimization across PSC
lines and across species. For example, Jeong and colleagues
adapted the protocol for mouse ESC inner ear organoid
(Koehler et al., 2013) to generate inner ear organoids
from human PSCs (Figure 3) (Jeong et al., 2018). Temporal
and spatial differences in gene expression across PSC lines
likely contributes to known variability and efficacy of
hair cell generation. Future improvements will occur as
we advance our understanding of hair cell development
or culture conditions.
Supporting cells of the sensory epithelia play an active
role in ion metabolism necessary for hair cell function.
The connexin proteins are themost abundant gap junction
proteins expressed in the supporting cells. Mutations in
GJB2, which encodes connexin 26 (CX26), are the most
common cause of autosomal recessive non-syndromic
sensorineural hearing loss (Kenna et al., 2010). In mouse
3D inner ear organoids, removing day 4 treatments (i.e., in-
hibition of BMP and activation of FGF) leads to increased
expression of CX26 in day 7 aggregates (Fukunaga et al.,
2016). Co-culturing the isolated small vesicles from day 7
aggregates with mouse cochlear feeder cells in 2D condi-
tions resulted in hemichannel formation that was disrup-
ted in CX26-deficient cell lines (Fukunaga et al., 2016).
This study highlights the use of PSCs to study otic support-
ing cells.
Neurons and Glia
Early neural induction protocols from PSCs involved using
stromal cells derived from skull bone marrow, which re-
sulted in efficient dopaminergic neuron production (Kawa-
saki et al., 2000; Ying et al., 2003). These protocols have
beenmodified to derive inner ear sensory neurons and glial
cells from PSCs (Figure 4). For example, mESCs treated with
retinoic acid (RA), basic FGF (bFGF), and BMP4were shown
to give rise to b-III tubulin+ and peripherin+ neurons (Cole-
man et al., 2007; Nayagam and Minter, 2012). However,1000 Stem Cell Reports j Vol. 14 j 996–1008 j June 9, 2020many of the available protocols are tailored to generate
dopaminergic neurons due to their role in neurodegenera-
tive disorders, such as Parkinson disease (Chen et al.,
2016b). In contrast, glutamate is the primary neurotrans-
mitter for the synaptic transmission between hair cells
and afferent sensory neurons within the inner ear (Oes-
treicher et al., 2002). Thus, the derivation of glutamatergic
neurons was a key step for recapitulating afferent neural
transmission in the inner ear. Reyes et al. (2008) used a
mESC line that transiently expressed Neurog1 along with
supplementation of brain-derived neurotrophic factor
(BDNF) and glia cell line-derived neurotrophic factor to
promote the differentiation of mESCs into glutamatergic
neurons both in vitro and in vivo. Forced expression of
Tlx3, a genetic switch capable of conferring a glutamatergic
over a GABAergic transmitter phenotype, promotes the
glutamatergic neuronal specification from mESCs (Kondo
et al., 2008).
Aswith the sensory epithelia in general, inner ear sensory
neurons are derived from the otic placode (Steventon et al.,
2014). Therefore, some of the early induction steps for
these sensory neurons were designed based on known
developmental trajectories of the otic placode. Small mole-
cules, such as FGFs, BMP, sonic hedgehog, and noggin are
used to support neuronal outgrowth from the otic placode
(Gunewardene et al., 2014;Matsuoka et al., 2017; Nayagam
et al., 2013; Needham et al., 2014; Perny et al., 2017). BDNF
and NT3 provide critical trophic support for inner ear sen-
sory neuron afferents in vivo (Fritzsch et al., 2004) and are
also used to support survival and growth of PSC-derived
neurons (Matsuoka et al., 2017; Perny et al., 2017; Shi
et al., 2007). Peripherin (which is specifically expressed
by type II spiral ganglion neurons [Huang et al., 2007]),
BRN3A (also known as POU4F1), and b-III tubulin are
commonly used to verify the formation of neurons, with
glutamate receptors and transporters subsequently ex-
ploited to confirm subtype-specific derivatives (Figure 4).
However, not all ESC-derived neurons within the same pro-
tocol express the same markers. Matsuoka et al. (2017)
showed that 90% of neuron-like cells were peripherin+
and b-III tubulin+, but only 46% were BRN3A+. Alterna-
tively, synaptic contacts and neural innervation between
co-existing hair cell-like cells and sensory neuron-like cells
will providemore convincing evidence as to the identity of
the derived cells.
To more precisely recapitulate the peripheral neuro-cir-
cuitry in vitro, a model that contains both sensory epithelia
and innervating neurons is needed. Currently, there are
two systems that potentially generate both tissues simulta-
neously (Figure 3). Treatment of hESCs with FGF3 and
FGF10 for 10–12 days in 2D culture gives rise to both otic
epithelial progenitors (OEPs) and otic neural progenitors
(ONPs), which can be distinguished based on their
Figure 4. Sensory Neuron-like Cells Derived from PSCs
Summary of induction strategies and characterization of mouse and human PSC-derived neuron-like cells. Petri dishes reflect adhesive 2D
cultures and cell aggregates represent 3D floating cultures. Characterization method highlighted in orange and key molecular markers
(percentage of cells expressing) are indicated. EB, embryonic body; d, culture day; RA, retinoic acid.
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derived fromOEP after the inhibition of Notch and supple-
mentation with RA and epidermal growth factor (Chen
et al., 2012; Lahlou et al., 2018b). Sensory neuron-like cells
can be derived from ONPs using bFGF and sonic hedgehog
followed by BDNF and NT3 supplementation (Chen et al.,
2012). Co-culture of these derived hair cells and sensory
neurons results in formation of neural connections
in vitro (Chen et al., 2018). However, this method required
separate induction protocols before the co-culture of
derived hair cells and sensory neurons.
On the other hand, 3D inner ear organoids contain both
sensory epithelia (hair cells and supporting cells) and sen-
sory neuron-like cells (Figure 3) (Jeong et al., 2018; Koehler
et al., 2013, 2017). Furthermore, several studies have repli-
cated these protocols (DeJonge et al., 2016; Schaefer et al.,
2018) and used the systems for different applications, such
as electrophysiological studies and disease modeling (Liu
et al., 2016; Tang et al., 2019). Although further character-
ization of sensory neuron-like cells is still in need, the inner
ear organoid system provides a powerful tool to study pe-
ripheral sensory neural networks in the inner ear in vitro.Human inner ear organoids derived from hPSCs also offer
the opportunity to explore developmental biology of the
human inner ear and understand the differences that exist
between mice and human inner ear development.
Stem Cell Therapy
Cell-based therapy aims at replacing lost or damaged tis-
sues via engraftment of viable transplanted cells or via
stimulation of endogenous self-healing pathways by tro-
phic factors (Jain, 2011). Recent advances in stem cell engi-
neering have made it possible to use cell-based therapy in
combatting disorders, such as cancer, cardiovascular dis-
ease, and neurodegeneration (Chopra et al., 2019; Goradel
et al., 2018; Vasic et al., 2019). Because mechanosensory
hair cells and their associated neurons in the mammalian
inner ears lack the capacity for regeneration (Kujawa and
Liberman, 2009), cell-based therapy may offer a viable
treatment option for inner ear disorders. Current chal-
lenges for cellular transplantation include cell survival
and differentiation after transplantation, particularly in
the scala media of the cochlea, which contains high potas-
sium endolymph. In addition, proper arrangement ofStem Cell Reports j Vol. 14 j 996–1008 j June 9, 2020 1001
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numerary hair cells in the cochlea does not restore function
(Chen and Segil, 1999). The challenges to neuronal trans-
plantation include establishing synaptic connections
with both the inner ear sensory cells and the brainstem.
Transplantation of Undifferentiated Stem Cells
Cellular transplantation of undifferentiated mESCs were
initially tested by injecting them directly into the healthy
rat cochlea (Hu et al., 2004).Migration of transplanted cells
along the auditory nerve toward the brain stem was de-
tected, yet only 1% of the transplanted cells survived
(Hu et al., 2004).When using animals with injured vestibu-
locochlear nerves, the survival rate of implanted mESCs
increased to over 60% 2 weeks after injection, but the sur-
vival rate drastically decreased to 25% 4 weeks after injec-
tion (Regala et al., 2005). During transplantation, the use
of BDNF improved the survival of donor cells and pro-
moted the neural differentiation, while the use of the extra-
cellular matrix enzyme ChABC (chondroitinase ABC
enzyme) improves donor cell migration (Palmgren et al.,
2012).
Most transplanted cells have been detected in the peri-
lymph spaces (Lang et al., 2008; Regala et al., 2005), while
a far lower percentage localized to the endolymph, where
the sensory epithelia reside (Lang et al., 2008). While the
majority of transplantation studies were carried out via
intra-cochlear sites, the feasibility of injecting mESCs into
the utricle was tested and a population of the injected
mESCs traveled to the perilymph space, with observation
of some cells in the vicinity of the cochlear sensory
epithelia and spiral limbus (Praetorius et al., 2008). When
mESCs were injected into the modiolus of the cochlea via
the scala tympani, transplanted cells were detected along
the vestibulocochlear nerve toward the brainstem and in
the endolymph compartment (Palmgren et al., 2012;
Zhao et al., 2013). Collectively, the site of injection appears
to determine the trajectory and final destination of the
transplanted ESCs.
In addition to cell survival and engraftment, it is impor-
tant to verify whether implanted PSCs can further differen-
tiate into inner ear cell types. Sakamoto and colleagues in-
jected EGFP reporter-tagged mESCs into adult mouse inner
ears and after 4 weeks observed differentiation of the trans-
planted cells marked by E-cadherin and neural cell adhe-
sion molecule, markers for the ectodermal lineage. Never-
theless, these transplanted cells did not differentiate
further into hair cells or neurons (Sakamoto et al., 2004).
Overall, many studies over the past 15 years have docu-
mented the engraftments of PSCs and improved the trans-
plantation procedures. Despite this success, the restoration
in hearing function has not yet been achieved using undif-
ferentiated PSCs as donor cells (Gokcan et al., 2016). In
addition, the concern remains with transplantation of un-1002 Stem Cell Reports j Vol. 14 j 996–1008 j June 9, 2020differentiated PSCs and the development of teratomas (Lee
et al., 2013).
Transplantation of Partially Differentiated Progenitors
Transplantation of partially differentiated progenitors from
PSCs could be safer and more efficacious since this
approach is less likely to result in teratoma formation
when compared with undifferentiated PSCs (Chen et al.,
2018; Fukuda et al., 2006) and is more likely to generate
terminally differentiated hair cells or neurons.
Neural progenitors derived from mESCs were first tested
in mouse cochleae where the transplanted progenitor cells
survived and underwent differentiation (Corrales et al.,
2006; Okano et al., 2005). Outgrowth of neurites from
transplanted cells toward damaged sensory epithelia was
observed, but restoration of function was not detected (Co-
leman et al., 2006; Corrales et al., 2006; Okano et al., 2005).
Synaptic connectivity between neurons and hair cells is
critical for proper inner ear function. Matsumoto et al.
(2008) co-cultured ESC-derived neurons and cochlear ex-
plants and observed establishment of synaptic contacts
with the inner hair cells in vitro. Similar re-integration be-
tween differentiated neurons and native hair cells was
confirmed using iPSC-derived progenitors (Nishimura
et al., 2009).
Many of the aforementioned early studies used the
‘‘stroma cell-derived inducing activity’’ protocol, which
was originally developed for the induction of dopami-
nergic neurons (Kawasaki et al., 2000), to derive neural pro-
genitors before transplantation to the inner ear (Matsu-
moto et al., 2008; Okano et al., 2005; Sakamoto et al.,
2004). The lack of glutamatergic phenotype may explain
the failed recovery of function in these studies even though
the synaptic connections were re-formed. More recently,
neural induction of iPSCs in a 3D collagen matrix followed
by transplantation into the scala tympani of the guinea-pig
cochleae resulted in glutamate transporter (VGlut1) expres-
sion in >50% of the transplanted neurons, yet only2% of
cells survived 2 weeks post-transplantation (Ishikawa et al.,
2017).
Transplantation of hESC-derived ONPs into gerbils with
selective loss of spiral ganglion neurons has led to
improvement in the auditory brainstem response 10 weeks
after transplantation. Neural cell bodies with processes ex-
tending to both cochlear hair cells and the cochlear nu-
cleus of the brainstem were observed (Chen et al.,
2012). Human iPSC-derived OEPs have been injected
into the modiolus of gerbil cochleae and the migration,
engraftment, and differentiation of transplanted progeni-
tor cells have been observed (Chen et al., 2018; Lopez-
Juarez et al., 2019). Furthermore, immunosuppression
with cyclosporine improved the quantity of engrafted
cells that migrated beyond the basilar membrane toward
the scala media (Lopez-Juarez et al., 2019). However, these
Figure 5. PSCs in Inner Ear Disease Modeling
Human and mouse ESCs and iPSCs in combination with genomic editing technologies (e.g., CRISPR/Cas9), provide powerful tools for
investigating disease mechanisms.
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(Chen et al., 2018).
In summary, when compared with undifferentiated
PCSs, partially differentiated progenitors show more
promising capacity for further differentiation, migration,
and engraftment after transplantation and the risk of ter-
atomas appears to be lower (Nishimura et al., 2012).
Despite the fact that restoration of auditory function
has not been consistently realized, significant progress
has been made with inner ear transplantation methodol-
ogies and survival of transplanted cells. Further studies to
understand how to tonotopically organize transplanted
cells, the mechanistic role of extracellular matrix compo-
nents in cell survival, and the presence and proliferation
of progenitor populations within the inner ear are needed
to realize stem cell therapy within the auditory and
vestibular system.
Modeling Inner Ear Disorders with PSCs
Modeling human inner ear disorders has relied heavily on
insights obtained from rodent models (Nist-Lund et al.,
2019; Straka et al., 2016; Wangemann, 2013). In addition,
the use of mammalian cochlear explants are generally
limited to neonatal mice due to the aforementioned tech-
nical difficulties associated with inner ear tissues at laterdevelopmental ages (Ogier et al., 2019). Another limiting
factor with primary cochlear explants is that cultures
cannot be maintained for longer than 14 days (Parker
et al., 2010; Sobkowicz et al., 1993). In contrast, inner ear
tissues generated from human and mouse PSCs can be
maintained for many weeks under proper culture condi-
tions. Furthermore, patient-specific, disease-associatedmu-
tations can be introduced in the genome of PSCs using
CRISPR/Cas9 genome editing technology to study the mo-
lecular mechanisms of genetic hearing loss.
Hundreds of genetic mutations are associated with hear-
ing loss, yet the specific mechanisms of deafness are un-
known for most genes. Barhl1 is homeobox gene ex-
pressed in hair cells and important for hair cell
maintenance. Constitutive expression of mutant Barhl1
in mESC-derived hair cells disrupts the derivation of
hair cells without altering the induction of early otic pro-
genitors (Zhong et al., 2018). It should be noted that
the mESCs were co-cultured with utricular stromal cells,
which can result in high variability across cultures. Subse-
quent RNA sequencing (RNA-seq) analysis revealed that
the integrity of the 30 enhancer region of Barh1 contains
a plausible binding site for ATOH1 and is critical for
proper hair cell differentiation (Hou et al., 2019)
(Figure 5).Stem Cell Reports j Vol. 14 j 996–1008 j June 9, 2020 1003
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3D organoids have been used to study hair cell degenera-
tion resulting from defective Tmprss3 (Figure 5). The type
II transmembrane serine protease, TMPRSS3, is required
for maintenance of hair cells in mice and as nonsense mu-
tation (Tmprss3Y260X) leads to rapid hair cell degeneration
at P12 in mice (Fasquelle et al., 2011). Mutations in
TMPRSS3 cause congenital or early-onset hearing loss in
humans (Scott et al., 2001), yet the functional role of
TMPRSS3 in the inner ear is not fully understood. ESC-
derived organoids from Tmprss3Y260X mice show normal
hair cell development followed by hair cell degeneration
at differentiation day 38 (equivalent to P14 in mouse)
(Tang et al., 2019). These observations are comparable
with phenotypes observed in Tmprss3Y260X mice. Further-
more, hair cells derived from CRISPR/Cas9-generated
Tmprss3 knockout (KO)mESCs showedmore severe degen-
eration than those derived from Tmprss3Y260X mESCs (Fig-
ure 5). These results demonstrate that the extent of degen-
eration varies across type of mutations (KO versus
truncation). The potential roles of TMPRSS3, including
the maintenance of intracellular ion homeostasis and
extracellularmatrix organization, in hair cells were inferred
by differential gene expression analyses using single-cell
RNA-seq (scRNA-seq) between wild-type and Tmprss3-KO
organoid hair cells (Tang et al., 2019). Together, this work
highlights the utility of PSC-derived organoid systems for
investigating the molecular mechanisms underlying ge-
netic inner ear disorders and will be vital for confronting
the high levels of genetic heterogeneity that have hindered
our understanding of the link between genetic mutations
and hearing loss (Van Camp et al., 1997).
In addition to recapitulating inner ear pathology caused
by genetic mutations, PSCs are also a powerful tool for
examining the effects of ‘‘genetic correction’’ in gene ther-
apy. Mutations inMYO7A andMYO15A are known human
deafness genes (Shearer et al., 1993). Hair cells derived from
patient-specific iPSC lines carrying MYO7A and MYO15A
mutations harbor abnormal stereocilia (Chen et al.,
2016a; Tang et al., 2016). After correction of genetic muta-
tions using CRISPR/Cas9 technology, derived hair cells
showed restored structure of stereocilia-like protrusions
and voltage-dependent currents and current densities
similar to controls (Figure 5) (Chen et al., 2016a; Tang
et al., 2016).
As an alternative to CRISPR-edited PSCs, patient-derived
iPSCs offer personalized human models for studying ge-
netic-associated inner ear disorders. iPSCs derived from
Pendred syndrome patients with biallelic SLC26A4 point
mutations have provided novel insights into how pendrin
protein dysfunction leads to hearing loss (Figure 5) (Hosoya
et al., 2017, 2019). Pendrin is an anion exchange protein
encoded by the gene SLC26A4 and a primary cause of1004 Stem Cell Reports j Vol. 14 j 996–1008 j June 9, 2020hair cell dysfunction was believed to stem from defects in
anion exchange (Hosoya et al., 2017). Outer sulcus cells
generated from these SLC26A4 mutant iPSCs demon-
strated aggregated mutant pendrin proteins within the
cytoplasm and exhibited decreased survival in response
to cell stress induced with proteasome inhibition. These
data suggest that hair cell dysfunction in Pendred syn-
dromemay result from aggregation ofmutant pendrin pro-
tein that results in susceptibility of cells to stress and cell
death. Furthermore, by testing patient-derived iPSCs,
they demonstrated that treatment with rapamycin, an
autophagy activator, increases cell survival and may atten-
uate the progression of hearing loss in patients with Pen-
dred syndrome (Figure 5) (Hosoya et al., 2017, 2019).
In summary, PSC-derived in vitro inner ear models offer
valuable tools for elucidating mutant genotype-associated
phenotypes, examining the effects of gene correction,
and investigating the molecular mechanisms underlying
the pathologies.
Conclusions and Future Perspectives
Significant progress has beenmade over the past 15 years in
applications of PSCs in inner ear therapies. Inner ear hair
cells, supporting cells, and neurons can now be generated
from both mouse and human PSCs, although reproduc-
ibility and scalability still pose challenges. Better under-
standings of inner ear development and incorporation of
such knowledge into the induction protocols will greatly
improve efficiency and reproducibility. PSC-derived otic
progenitors have shown the capacity for differentiation,
migration, and engraftment with native tissues after trans-
plantation in rodent models (Figure 5). However, there re-
mains the risk of the formation of teratomas. Reduction
of this potential side effect has been demonstrated using
partially differentiated PSCs, yet discovery of novel
methods to regulate off target differentiation in vivo is
needed.
PSC-derived inner ear tissues, especially those from pa-
tient-specific iPSCs, provide powerful tools for unveiling
disease mechanisms that were previously difficult, if not
impossible, to examine. Stem cell-derived inner ear organo-
ids along with scRNA-seq can provides mechanistic in-
sights into genetic deafness (Figure 5). Human PSC-based
organoid studies in vitro may be directly translatable to pa-
tients in vivo. Current limitations to the use of PSCs to study
and treat inner ear disorders include labor-intensive culture
protocols, variable efficiency of tissue derivation, inability
to derive cochlear tissues in 3D organoids, limited differen-
tiation and integration in host tissues, and inability to
study age-related disorders. Opportunities for future trans-
lation in the field lie in optimization of gene therapies,
personalized cell transplantation therapeutics, and drug
screening for hair cell regeneration or ototoxicity.
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